SBI reported a standalone net profit of Rs 16,891.44 crore for the quarter ended December 31, 2024, which was 84.3 per cent ...
Systematix Institutional Equities said FMCG business growth may moderate in near term on depressed urban consumption, and margins will likely downtrend given inflation and price lags.
Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...
SBI's net interest income (NII) for Q3FY25 rose by 4.09% YoY, totaling Rs 41,620 crore, compared to Rs 39,816 crore in the ...